- Report
- February 2024
- 250 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- February 2024
- 148 Pages
Global
From €3605EUR$3,783USD£3,093GBP
€4241EUR$4,450USD£3,638GBP
- Report
- March 2024
- 197 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- February 2024
- 250 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €7577EUR$7,950USD£6,500GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,226GBP
- Report
- October 2023
- 185 Pages
Global
€4570EUR$4,795USD£3,920GBP
- Report
- November 2023
- 115 Pages
United States
From €3574EUR$3,750USD£3,066GBP
- Report
- February 2023
- 250 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- May 2020
- 117 Pages
Global
From €3955EUR$4,150USD£3,393GBP
- Report
- September 2020
- 117 Pages
North America
From €2002EUR$2,100USD£1,717GBP
€2859EUR$3,000USD£2,453GBP
- Report
- August 2022
- 120 Pages
Global
From €4527EUR$4,750USD£3,884GBP
- Report
- August 2020
- 111 Pages
Global
From €4051EUR$4,250USD£3,475GBP
- Report
- August 2023
- 75 Pages
India
From €3336EUR$3,500USD£2,862GBP
- Report
- December 2022
- 115 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Report
- April 2021
- 50 Pages
China
From €2478EUR$2,600USD£2,126GBP
- Report
- September 2022
- 145 Pages
Global
From €4051EUR$4,250USD£3,475GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- May 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,167GBP
Hydroxychloroquine is a drug used to treat immune disorders, such as lupus and rheumatoid arthritis. It is an antimalarial drug, meaning it is used to prevent and treat malaria. It is also used to treat other autoimmune diseases, such as discoid lupus erythematosus and systemic lupus erythematosus. Hydroxychloroquine is a relatively safe drug, with few side effects. It is also relatively inexpensive, making it a popular choice for treating immune disorders.
Hydroxychloroquine is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms. It is also available in combination with other drugs, such as methotrexate and sulfasalazine.
The hydroxychloroquine market is highly competitive, with many companies offering the drug. Some of the companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Pfizer. Show Less Read more